Pfizer, docs: New cancer pill gives hope, strategy

August 30, 2011 1:14:19 PM PDT
Pfizer Inc.'s just-approved Xalkori, the first new medicine in more than six years for deadly lung cancer, proves the value of precisely targeting rare diseases linked to gene variants, cancer specialists and Pfizer executives said Tuesday.